Hepatology

• In the Journals Perspective

• Universal screening for hepatitis B may be cost-effective strategy

• March 26, 2013
• Vaccination with hepatitis B immunoglobulin for neonates of hepatitis B surface antigen carrier mothers is a cost-effective addition to universal...More »

• Meeting News Coverage

• Risk for HCV infection greater with heroin use than prescription opioids

• March 20, 2013
• Heroin injection increases the risk for hepatitis C infection more than the injection of prescription opioids among at-risk youth, according to data...More »

• In the Journals

• Long-term effects similar for two-, three-dose regimens of hepatitis A vaccine

• March 19, 2013
• Patients vaccinated against hepatitis A using a three-dose regimen were similarly protected compared with two-dose recipients more than 14 years later in...More »

• In the Journals

• Patients with HCV who failed prior therapy benefited from vaniprevir/peginterferon/ribavirin

• March 15, 2013
• The addition of vaniprevir to pegylated interferon and ribavirin significantly improved sustained virologic response among patients with chronic hepatitis...More »

• Spending on HCV, specialty medications rose sharply in 2012

• March 11, 2013
• Consumer spending on drugs to treat complex illnesses, particularly hepatitis C, increased substantially during 2012, while costs for traditional...More »

• In the Journals

• High viral load, HBeAg positivity increased risk for mother-to-infant HBV transmission

• March 8, 2013
• Infants born to mothers with a high hepatitis B viral load, particularly those positive for hepatitis B e antigen, are at high risk for contracting...More »

• FDA approves test measuring hepatitis C treatment response via HCV RNA levels

• March 6, 2013
• The FDA has approved a viral load assay for patients with chronic hepatitis C undergoing antiviral treatment.
  The in vitro nucleic acid amplification test,...More »

• Meeting News Coverage

• Ledipasvir combination effective in treating HCV genotype 1

• March 5, 2013
• ATLANTA — A combination of sofosbuvir, ledipasvir and ribavirin led to 100% viral suppression among patients with hepatitis C virus genotype 1,...More »

• In the Journals

• Rapid tests effectively detected HBsAg

• March 5, 2013
• Three rapid tests conducted at various Paris-based health care centers effectively screened patients and detected hepatitis B surface antigen, according...More »

• Meeting News Coverage

• Sofosbuvir combination efficacious in difficult-to-treat HCV patients

• Infectious Disease News, April 2013
• ATLANTA — Among a population of patients with hepatitis C that are typically difficult to treat, sofosbuvir with weight-based ribavirin demonstrated...More »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!